Secretory phospholipase A2-IIa, a potential biomarker for prostate cancer, is regulated by the HER/HER2-elicited pathway

被引：0
|
作者：
Oleksowicz, Leslie
Liu, Yin [1 ]
Bracken, R. Bruce
Gaitonde, Krishnanath
Burke, Barbara
Succop, Paul
Levin, Linda
Dong, Zhongyun
Lu, Shan [1 ]
机构：
[1] Univ Cincinnati, Coll Med, Dept Pathol, Cincinnati, OH 45237 USA
来源：
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 2011年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
296
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [41] Association of 5′UTR polymorphism of secretory phospholipase A2 group IIA (PLA2G2A) gene with prostate cancer metastasis
    Ozturk, Kaan
    Onal, Meltem Selen
    Efiloglu, Ozgur
    Nikerel, Emrah
    Yildirim, Asif
    Telci, Dilek
    GENE, 2020, 742
  • [42] Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer
    Shi, Hong-Zhi
    Wang, Yu-Ning
    Huang, Xiao-Hui
    Zhang, Ke-Cheng
    Xi, Hong-Qing
    Cui, Jian-Xin
    Liu, Guo-Xiao
    Liang, Wen-Tao
    Wei, Bo
    Chen, Lin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (10) : 1836 - 1842
  • [43] Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer
    Hong-Zhi Shi
    Yu-Ning Wang
    Xiao-Hui Huang
    Ke-Cheng Zhang
    Hong-Qing Xi
    Jian-Xin Cui
    Guo-Xiao Liu
    Wen-Tao Liang
    Bo Wei
    Lin Chen
    World Journal of Gastroenterology, 2017, (10) : 1836 - 1842
  • [44] HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer
    Sanghoon Han
    Sungjin Park
    Jungsuk An
    Jun-Young Yang
    Jun-Won Chung
    Yoon Jae Kim
    Kyoung Oh Kim
    Dong Kyun Park
    Kwang An Kwon
    Woon Kee Lee
    Seungyoon Nam
    Jung Ho Kim
    Scientific Reports, 10
  • [45] HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer
    Han, Sanghoon
    Park, Sungjin
    An, Jungsuk
    Yang, Jun-Young
    Chung, Jun-Won
    Kim, Yoon Jae
    Kim, Kyoung Oh
    Park, Dong Kyun
    Kwon, Kwang An
    Lee, Woon Kee
    Nam, Seungyoon
    Kim, Jung Ho
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [46] EXPRESSION OF HER2 IN RECTAL CANCER WITH PREOPERATIVE RADIOTHERAPY POTENTIAL BIOMARKER TO PREDICT THE METASTASIS
    Yao, Y.
    Du, C.
    Chen, P.
    Chen, N.
    Gu, J.
    DISEASES OF THE COLON & RECTUM, 2013, 56 (04) : E89 - E90
  • [47] HER2 as a potential biomarker guiding adjuvant chemotherapy in stage II colorectal cancer
    Feng, Yang
    Li, Yaqi
    Huang, Dan
    Cai, Sanjun
    Peng, Junjie
    EJSO, 2019, 45 (02): : 167 - 173
  • [48] Spatial HER2 heterogeneity on HER2-PET in HER2-low and negative disease: potential biomarker for antibody-drug conjugate effect
    Schroder, Carolien
    van Geel, Jasper
    Eisses, Bertha
    Brouwers, Adrienne
    Elias, Sjoerd
    Bensch, Frederike
    Kuip, Evelien
    Jager, Agnes
    Glaudemans, Andor
    van der Vegt, Bert
    van Oordt, Willemien Menke-van der Houven
    de Vries, Elisabeth
    CANCER RESEARCH, 2024, 84 (09)
  • [49] HER-2 and topoisomerase IIa gene alterations in male breast cancer
    Rudlowski, C.
    Wardelmann, E.
    Merkelbach-Bruse, S.
    Buettner, R.
    Kuhn, W.
    Schildhaus, H-U
    CANCER RESEARCH, 2009, 69 (02) : 288S - 289S
  • [50] Coexpression of HER2 and TOP2A in prostate cancer correlates with gleason score and HER2 amplification
    Murphy, A
    Hughes, C
    Barrett, C
    Magee, H
    Sheils, O
    O'Leary, J
    Loftus, B
    MODERN PATHOLOGY, 2006, 19 : 151A - 151A
12345